IP Group

AccelerComm Ltd provides Forward Error Correction (FEC) or channel coding solutions. It provides error correction decoder for markets, such as 3G and 4G Mobile handsets and base stations, satellite standards, and communication applications. The company’s products, include Polar, 3GPP Compliant Encoding/Decoding Chain; Turbo Decoder; and LDPC, 3GPP Compliant LDPC Encoding/Decoding Chain. AccelerComm Ltd was incorporated in 2016 and is based in Southampton, United Kingdom.

Intrinsic Semiconductor Technologies is established to developed silicon-oxide based RRAM technologies. Intrinsic's technology is fully air stable and inherently CMOS compatible. Intrinsic's core technology can be configured as non-volatile memory, multilevel memory, hardware acceleration for Machine Learning, and neuromorphic devices.

AMSL Aero Pty Ltd designs and manufactures electric plane. VERTIIA, an electric aircraft allows urban and regional passenger transportation, cargo transportation, and aeromedical transportation. AMSL Aero Pty Ltd was incorporated in 2017 and is based in Stanmore, Australia.

Abliva AB is a biotechnology company based in Lund, Sweden, that specializes in the research and development of mitochondrial medicine. The company is advancing several drug candidates, including KL1333, which is in Phase I clinical trials for chronic treatment of primary mitochondrial diseases, and NV354, which is being prepared for clinical trials targeting Complex I deficiency in mitochondrial diseases. Additionally, Abliva is developing NeuroSTAT for the treatment of traumatic brain injuries and is currently engaged in a Phase II/III adaptive clinical study for this indication. The company also has a cyclophilin-D-inhibiting cyclosporine, CicloMulsion®, undergoing a Phase III clinical study for reperfusion injury. Abliva collaborates with various institutions and organizations, including academic hospitals and pharmaceutical companies, to enhance its research and development efforts. Founded in 2000 and previously known as NeuroVive Pharmaceutical AB, the company rebranded to Abliva AB in May 2020.

MoA Technology Ltd. is a plant genetics company based in Leeds, United Kingdom, that specializes in developing sustainable agricultural technologies. Founded in 2017 as a spin-out from the University of Oxford, the company focuses on discovering new herbicide chemistries with innovative modes of action derived from both natural and synthetic sources. By utilizing a proprietary in vivo plant-based genomic process, MoA Technology identifies specific target proteins linked to these new modes of action, thus providing farmers with a diverse range of effective weed control solutions. The company's approach aims to enhance food production while promoting sustainable crop systems.

Slamcore Limited specializes in developing simultaneous localization and mapping (SLAM) solutions for applications in augmented and virtual reality, robotics, and autonomous vehicles. Founded in 2016 and based in London, the company focuses on making commercial-grade spatial intelligence accessible. Its advanced SLAM software enables robots and drones to effectively navigate and comprehend their environment, utilizing methods such as Visual SLAM, sensor fusion, and Event Camera SLAM. These technologies allow for real-time processing and integration of data from various sensors, enhancing capabilities in areas like motion estimation and panorama reconstruction. Slamcore collaborates with partners to optimize the interplay between software and hardware, ensuring a balanced approach to performance and cost-effectiveness. By providing robust SLAM algorithms, the company aims to transform spatial AI into practical solutions for various industries, ultimately facilitating the integration of robots into everyday life.

Gripable is develops simple digital therapy tools, combining them with mobile games, motivating physically impaired patients. GripAble began during our research with stroke patients struggling to use their hands for simple activities. Everyday tasks - getting dressed in the morning, holding a glass of water - are a huge frustration for them. This is the reality for over 500 million people around the world suffering with impaired arm mobility. These patients need, and want, more therapy. GripAble's first product is a highly sensitive, portable hand-grip that connects wirelessly with a mobile-based app, allowing patients to play our fun therapy games. It is designed for low-cost, easy-access assessment and therapy of hand and arm disability, providing increased engagement and allowing for self-training in hospitals and at home.

Kynos Therapeutics develops KMO inhibitors across key indications in inflammation, immunity, and metabolism.

Aptatek Biosciences Inc manufactures portable disease management devices for people suffering with Phenylketonuria (PKU). The products can be used to monitor phenylalanine levels. The product provides real time analyses and reports of blood using sensor technology. Aptatek Biosciences Inc is based in Princeton, New Jersey.

VYTAL Global GmbH, founded in 2019 and based in Cologne, Germany, operates a digital reusable system aimed at reducing single-use packaging waste in the food industry. The company offers an application that enables consumers to select reusable bowls instead of disposable ones when ordering take-away or delivery food. Users can borrow bowls by displaying a QR code from the app or their membership card, and return them at any partner location or designated return boxes. VYTAL serves a wide range of stakeholders, including consumers, restaurants, canteens, caterers, and municipalities. In response to the significant environmental impact of single-use packaging, which generates substantial waste and greenhouse gas emissions, VYTAL positions itself as a sustainable alternative, promoting a circular economy within the growing market for convenience and delivery food.

Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.

Bramble Energy Ltd. is a London-based company that specializes in the design, development, and manufacture of printed circuit board fuel cells (PCBFCs). Leveraging its expertise in the high-volume printed circuit board industry, the company produces a range of fuel cell products, including 20 W, 500 W, and 5 kW PCBFC stacks, as well as custom-designed solutions. Bramble Energy aims to supply gigawatts of fuel cell hardware, positioning itself as a leader in the energy technology sector. Its innovative approach caters to various applications across the stationary, portable, automotive, and mobility sectors. Founded in 2015, Bramble Energy is focused on delivering high-performance and cost-effective fuel cell solutions.

First Light Fusion Limited is a company focused on developing advanced implosion processes for electricity generation. Founded in July 2011 as a spin-out from the University of Oxford, the company initially operated under the name Oxyntix Ltd. until a rebranding in June 2014. The founders, Professor Yiannis Ventikos and Dr. Nicholas Hawker, have backgrounds in mechanical engineering and academia. Based in Begbroke, United Kingdom, First Light Fusion employs a team of engineers and physicists and maintains collaborations with several prestigious academic institutions, including the University of Oxford, Warwick University, University College London, and Imperial College London. The company's mission is to innovate in the field of energy generation through cutting-edge research and technology.

Microbiotica Limited is a biotechnology company based in Cambridge, United Kingdom, founded in 2016. The company specializes in the development of human microbiome-based therapeutics and biomarkers. Its platform is designed to identify gut bacteria associated with specific phenotypes, offering a high level of precision. This capability allows researchers to determine phenotypes before conducting tests on candidate bacteria using advanced in vitro and in vivo models. By focusing on the science of the microbiome, Microbiotica aims to advance the understanding and application of live bacterial therapeutics in clinical settings.

Diffblue is changing the way software is developed using Artificial Intelligence (AI). Diffblue Cover, the company’s first product, automatically generates tests for Java code to enable development teams to deliver higher quality software, faster. Diffblue’s technology is developed by its team of leading experts in AI, software verification and synthesis, and customers include Goldman Sachs and Amazon Web Services. Diffblue is backed by Oxford University, Oxford Sciences Innovation and Goldman Sachs and is headquartered in Oxford, UK.

Canopus Networks Pty Ltd is an Australian company founded in 2018, specializing in software-defined networking and artificial intelligence technologies. The company focuses on providing solutions for internet service providers to effectively manage and isolate streaming video and gaming traffic, ensuring a consistent user experience during network congestion. Canopus develops a platform that offers encryption-proof network observability, enabling high-speed analysis of network flows. This platform is essential for telecommunications operators who need to monitor application and network performance amidst increasing data rates and encryption challenges. Canopus serves various sectors, including fixed operators, gaming, 5G mobile operators, live video streaming, business applications, security, and government entities.

Navenio is a software technology company that provides location-based services for indoor environments via mobile applications. Its solution provides an improvement on other indoor localization technologies, having the ability to locate people without the need for implementing, managing, or surveying any new building hardware such as beacons or wi-fi. Navenio’s intelligent workforce solution unlocks significant improvements in the efficiency and workflow of staff and teams through automation that is carefully driven from real-world best practice. The company was founded in 2015 and is headquartered in Oxford, England.

Ieso Digital Health Ltd. specializes in providing online evidence-based cognitive behavioral therapy (CBT) to individuals facing various mental health challenges, including anxiety and depression. The company's unique online service facilitates real-time communication between accredited therapists and patients through a secure virtual environment, where sessions are conducted via text. This approach not only mirrors traditional face-to-face interactions but also offers greater convenience for users. Ieso began its operations in the UK in 2000 and has since expanded into the US market, collaborating with Medicaid and commercial health plans to enhance access to mental health services. The company’s therapy model has demonstrated effectiveness, requiring fewer sessions to achieve recovery and showing improved outcomes compared to conventional therapy methods. Ieso serves a diverse clientele, including health providers, private individuals, and businesses, and is recognized for its rapid growth in the digital health sector.

Arkivum delivers software, services and domain expertise for long term data management and digital preservation globally. We serve organisations around the world in data intensive and regulated markets. We make your long term data secure, accessible and usable for as long as you need it, providing assurance your data is where you need it, when you need it. Our domain expertise means we can guarantee 100% data integrity and best practice guidance for dealing with new compliance requirements as they are introduced. Our vendor neutral technology and no data lock-in means your data lives where you want it to and you own your data at all times. Arkivum delivers complete confidence in preserving, meeting complex compliance and regulatory requirements and creating business value from your data. Bringing your archived data to life.

Mobilion Systems, Inc. is a biotechnology company based in Chadds Ford, Pennsylvania, that specializes in advanced ion mobility separation technology known as structures for lossless ion manipulation (SLIM). Founded in 2015, the company focuses on identifying and analyzing difficult-to-detect molecules, particularly those relevant to biologic therapeutics and disease diagnostics. Mobilion's innovative SLIM technology allows for the separation and detection of clinically significant biomolecules that conventional instruments struggle to identify. By providing enhanced sensitivity, resolution, and throughput, Mobilion's analytical instruments support the development of improved therapeutics and enable earlier disease detection, ultimately aiming to address diseases at their core rather than merely treating symptoms.

Pulmocide Ltd, a company focused on the discovery and development of a new generation of inhaled medicines for the treatment of serious viral and fungal infections of the respiratory tract.

Oxford Nanopore Technologies Limited specializes in the development and commercialization of nanopore-based electronic systems for the analysis of single molecules, particularly in the fields of DNA and RNA sequencing. The company offers a range of products, including the portable MinION device for molecular analysis, the benchtop PromethION for large-scale sequencing projects, and the GridION system suitable for various molecular sensing applications. Their technology supports diverse scientific research areas such as genomics, cancer studies, microbiology, and environmental research, with applications extending to healthcare, agriculture, and food safety. The Flongle device caters to on-demand sequencing needs, while the MinIT accessory enhances the functionality of their sequencing devices. Oxford Nanopore’s innovative technology emphasizes accessibility and ease of use, with rapid library preparation and automated processes. Founded in 2005 and headquartered in Oxford, United Kingdom, the company operates additional offices worldwide, enabling its products to be utilized in over 80 countries.

Intrinsic Semiconductor Technologies is established to developed silicon-oxide based RRAM technologies. Intrinsic's technology is fully air stable and inherently CMOS compatible. Intrinsic's core technology can be configured as non-volatile memory, multilevel memory, hardware acceleration for Machine Learning, and neuromorphic devices.

Carisma Therapeutics is a biotechnology company focused on developing innovative cellular immunotherapies to treat solid tumors. Founded in 2016 and based in Philadelphia, Pennsylvania, the company specializes in creating CAR macrophages, which utilize chimeric antigen receptor technology and adoptive cell transfer. This approach aims to enhance cancer treatment by enabling macrophages to infiltrate solid tumor microenvironments, thereby providing robust cellular immunotherapy options for patients. Carisma leverages advancements in macrophage biology and engineering to improve therapeutic outcomes in oncology.

Precision Ocular Metrology is a medical device startup dedicated to revolutionizing the way we measure ocular surface topography. Standard Placido disk slope measurements are great for optical power measurements on the central regions of the cornea but provide poor elevation topography, making them poor choices for specialty lens fitting. Our sMap3D topographer addresses this problem by providing direct anterior surface elevation measurements, letting you map the complete three-dimensional eye surface with an unprecedented 10 um precision.

C-Capture Ltd utilise their extensive knowledge of CO2 (carbon dioxide) based chemistry and engineering, to develop a bottom-up approach to designing solvent systems for the removal of CO2 from gas streams. CO2 is considered to be a ‘greenhouse gas’ and its release into the atmosphere is one of the leading contributors to global warming.

Carisma Therapeutics is a biotechnology company focused on developing innovative cellular immunotherapies to treat solid tumors. Founded in 2016 and based in Philadelphia, Pennsylvania, the company specializes in creating CAR macrophages, which utilize chimeric antigen receptor technology and adoptive cell transfer. This approach aims to enhance cancer treatment by enabling macrophages to infiltrate solid tumor microenvironments, thereby providing robust cellular immunotherapy options for patients. Carisma leverages advancements in macrophage biology and engineering to improve therapeutic outcomes in oncology.

Oxbotica is developing the next generation of autonomous vehicles - creating the software that makes them go. Using the latest in computer vision and machine learning, their systems learn from their environment and share experiences with each other, so that they're getting smarter all the time. The system uses a complement of sensors and algorithms to identify and track pedestrians, cars and other obstacles in the environment.

AudioScenic Limited, founded in 2017 and based in Southampton, United Kingdom, specializes in the development of innovative 3D audio technology that integrates head-tracking with listener-adaptive loudspeaker arrays. The company aims to transform audio experiences in various sectors, including cinema, gaming, production, portable devices, and automotive applications. By utilizing small arrays of speakers and advanced head-tracking technologies, AudioScenic delivers immersive sound without the need for headphones or conventional speaker setups. This technology allows sound to be projected directly to the listener's ears, creating a superior spatial audio experience that simulates 3D sound positioning. The proprietary head-tracking feature ensures that audio beams adjust dynamically to the listener's movements, eliminating the limitations of traditional setups. AudioScenic offers scalable solutions tailored to diverse platforms, providing detailed acoustic design support to implement its audio systems effectively. The company's Virtua 3D Engine, which employs patented signal processing techniques, enables cost-effective implementations across a range of products, reinforcing its commitment to enhancing audio quality in both personal and public spaces.

Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.

AccelerComm Ltd provides Forward Error Correction (FEC) or channel coding solutions. It provides error correction decoder for markets, such as 3G and 4G Mobile handsets and base stations, satellite standards, and communication applications. The company’s products, include Polar, 3GPP Compliant Encoding/Decoding Chain; Turbo Decoder; and LDPC, 3GPP Compliant LDPC Encoding/Decoding Chain. AccelerComm Ltd was incorporated in 2016 and is based in Southampton, United Kingdom.

Mobilion Systems, Inc. is a biotechnology company based in Chadds Ford, Pennsylvania, that specializes in advanced ion mobility separation technology known as structures for lossless ion manipulation (SLIM). Founded in 2015, the company focuses on identifying and analyzing difficult-to-detect molecules, particularly those relevant to biologic therapeutics and disease diagnostics. Mobilion's innovative SLIM technology allows for the separation and detection of clinically significant biomolecules that conventional instruments struggle to identify. By providing enhanced sensitivity, resolution, and throughput, Mobilion's analytical instruments support the development of improved therapeutics and enable earlier disease detection, ultimately aiming to address diseases at their core rather than merely treating symptoms.

Bramble Energy Ltd. is a London-based company that specializes in the design, development, and manufacture of printed circuit board fuel cells (PCBFCs). Leveraging its expertise in the high-volume printed circuit board industry, the company produces a range of fuel cell products, including 20 W, 500 W, and 5 kW PCBFC stacks, as well as custom-designed solutions. Bramble Energy aims to supply gigawatts of fuel cell hardware, positioning itself as a leader in the energy technology sector. Its innovative approach caters to various applications across the stationary, portable, automotive, and mobility sectors. Founded in 2015, Bramble Energy is focused on delivering high-performance and cost-effective fuel cell solutions.

MISSION Therapeutics Ltd. is a biotechnology company based in Cambridge, United Kingdom, focused on discovering and developing small-molecule drugs that selectively target deubiquitylating enzymes (DUBs). The company's pipeline includes promising candidates such as USP30, which is aimed at treating Parkinson's disease and cancer, and USP7, which is recognized as a significant target in oncology. In addition to these, MISSION Therapeutics has various DUB programs that address conditions in oncology, neurodegeneration, rare mitochondrial diseases, kidney disease, and inflammation. Founded in 2011, the company is actively engaged in advancing its innovative drug development platform, which capitalizes on the ubiquitin pathway to enhance protein homeostasis and offers potential therapeutic options in several challenging medical areas.

Navenio is a software technology company that provides location-based services for indoor environments via mobile applications. Its solution provides an improvement on other indoor localization technologies, having the ability to locate people without the need for implementing, managing, or surveying any new building hardware such as beacons or wi-fi. Navenio’s intelligent workforce solution unlocks significant improvements in the efficiency and workflow of staff and teams through automation that is carefully driven from real-world best practice. The company was founded in 2015 and is headquartered in Oxford, England.

IBEX Innovations Limited specializes in the development and commercialization of advanced X-ray detector technology that enhances material analysis capabilities. The company's proprietary multi absorption plate (MAP) technology integrates with standard X-ray detectors, enabling high sensitivity material classification while maintaining key performance characteristics such as speed and spatial resolution. This innovative solution is applicable across various sectors, including medical imaging, electronics, food safety, and security. Founded in 2010 by Dr. Gary Gibson and based in Sedgefield, United Kingdom, IBEX has rapidly evolved from its initial concept to a recognized provider of engineered solutions. The company collaborates with academic and healthcare institutions, including Durham University and NHS trusts, to validate and advance its technology. IBEX Innovations has received support from venture capital firms and grants from InnovateUK and the European Commission to foster its growth and development.

Quantum Motion Technologies Limited is focused on developing a technology platform that utilizes an array of qubits to create innovative quantum computing architectures. Established in 2017 and based in Leeds, United Kingdom, the company aims to build a universal quantum computer using silicon and CMOS-compatible processes. Its quantum computing technology is designed to address complex challenges across various fields, including chemistry, medicine, and artificial intelligence.

RFC Power Ltd develops low-cost hybrid gas-liquid flow battery chemistry, leveraging concepts from fuel cells. The company was founded in 2017 and is based in London, United Kingdom.

Instrumems Inc. develops nano-wire sensors, a sensing platform that allows measuring of temperature, velocity, and humidity. The company was founded in 2016 and is based in Los Altos, California.

Mixergy Ltd, founded in 2014 and based in Cassington, United Kingdom, specializes in the development of energy storage solutions, particularly hot water tanks. The company provides a cost-effective means to enhance energy efficiency and support renewable energy generation by improving grid balancing. Mixergy's innovative tanks are designed to optimize the use of solar photovoltaic systems and heat pumps, thereby enabling better energy utilization and contributing to sustainable energy practices.

Mobilion Systems, Inc. is a biotechnology company based in Chadds Ford, Pennsylvania, that specializes in advanced ion mobility separation technology known as structures for lossless ion manipulation (SLIM). Founded in 2015, the company focuses on identifying and analyzing difficult-to-detect molecules, particularly those relevant to biologic therapeutics and disease diagnostics. Mobilion's innovative SLIM technology allows for the separation and detection of clinically significant biomolecules that conventional instruments struggle to identify. By providing enhanced sensitivity, resolution, and throughput, Mobilion's analytical instruments support the development of improved therapeutics and enable earlier disease detection, ultimately aiming to address diseases at their core rather than merely treating symptoms.

Kira Biotech Pty Ltd is an Australian biotechnology company focused on developing innovative immunomodulatory compounds for treating immune system disorders, including rheumatoid arthritis, systemic lupus erythematosus, and type 1 diabetes. Established in 2017 and based in Brisbane, Kira Biotech is advancing its lead candidate, KB312, a first-in-class selective monoclonal antibody designed to target activated immune cells. This approach aims to restore immune system balance by inducing tolerance. The company has secured venture capital funding and is currently progressing KB312 through preclinical development and phase 1 clinical trials, guided by a team of experts in drug development, including prominent US-based rheumatologist and immunologist Dr. Dan Baker.

Inflowmatix Limited designs and implements electronic systems that provide water flow and system health analytics to water utilities worldwide. Its system provides energy efficient operation of water supply networks by monitoring and analyzing the fluid dynamics in various networks, as well as improves the management of leakage, demand, energy, and operational incidents. The company’s system also enables water companies to monitor the condition of critical assets, optimize network performance, and extend the life of ageing infrastructure by providing visibility into the hydraulic behavior of large scale networks. Inflowmatix Limited was founded in 2015 and is headquartered in London, United Kingdom.

TrekIT provides clinicians with an intuitive, patient-centric task management tool to track, manage and coordinate clinical care. Easily assign, date and time tasks, categorize them for when they are due, view cleared tasks and more.

Growave is an Agtech startup company offering herbicide free weed management.

WaveOptics, Ltd. specializes in the design and manufacture of augmented reality display technology, focusing on optical waveguides for wearable devices. The company offers features such as binocular displays, high field-of-view, and full RGB color in lightweight designs. Founded in 2014 and based in Abingdon-on-Thames, United Kingdom, WaveOptics has established strategic partnerships with companies like Compal, Wistron, and Plessey to enhance its product offerings. The company aims to be a pivotal supplier of optical components for the growing augmented reality market.

Exyn Technologies, Inc. is a Philadelphia-based company specializing in autonomous aerial robotics, having emerged from the GRASP Laboratory at the University of Pennsylvania. Founded in 2014, the company has developed exynAI, a modular software system that enables pilot-less flights for drones in complex commercial settings. This technology leverages multiple redundant sensors and advanced mapping techniques to facilitate obstacle avoidance and autonomous flight planning, allowing for applications such as underground inspections, inventory management, and construction documentation. Exyn's drones operate without human control or GPS, making them particularly suited for navigating challenging environments and automating hazardous tasks.

Azuri Technologies Ltd. develops, manufactures, and installs solar power products for off-grid emerging markets in Africa and the United Kingdom. The company offers AzuriTV, a solar-powered television; Indigo, a pay-as-you-go system that enables solar electricity to be delivered as a service using scratch cards for payment; Azuri Quad, a solar home system that provides household lighting, including LED lights, rechargeable radio and torch, and mobile phone charging; and PayGo, a solar home system that delivers clean energy to rural households living without electricity. The company was founded in 2012 and is based in Cambridge, United Kingdom with distribution networks in Kenya, Uganda, South Sudan, Zambia, and South Africa.

IBEX Innovations Limited specializes in the development and commercialization of advanced X-ray detector technology that enhances material analysis capabilities. The company's proprietary multi absorption plate (MAP) technology integrates with standard X-ray detectors, enabling high sensitivity material classification while maintaining key performance characteristics such as speed and spatial resolution. This innovative solution is applicable across various sectors, including medical imaging, electronics, food safety, and security. Founded in 2010 by Dr. Gary Gibson and based in Sedgefield, United Kingdom, IBEX has rapidly evolved from its initial concept to a recognized provider of engineered solutions. The company collaborates with academic and healthcare institutions, including Durham University and NHS trusts, to validate and advance its technology. IBEX Innovations has received support from venture capital firms and grants from InnovateUK and the European Commission to foster its growth and development.

Storm Therapeutics Limited is a biotechnology company based in Cambridge, United Kingdom, focused on discovering and developing small molecule drugs that target RNA-modifying enzymes for cancer treatment. Established in 2015, the company aims to create novel therapeutics by targeting pathways involved in RNA modification. Originally known as Iceni Therapeutics Limited, it rebranded to Storm Therapeutics in June 2016. Through its innovative approach, Storm Therapeutics seeks to advance cancer therapeutics by leveraging the role of RNA in cellular processes.

Aqdot Limited, founded in 2012 and located in Cambridge, United Kingdom, specializes in the manufacturing of smart microcapsules with customizable properties tailored for various industries. The company has developed a unique one-step shrink-wrap approach that combines emulsion technology and supramolecular chemistry, simplifying the microencapsulation process. This innovative technology promotes energy and raw material efficiency, resulting in reduced energy consumption and waste production. Aqdot's microcapsules have potential applications across multiple sectors, including encapsulating enzymes for laundry detergents and fertilizers in agriculture. The microencapsulation market is substantial, with established uses in household and personal care products, food, and agrochemicals.

Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis to improve testing and treatment for oncologists and their patients. Unlike conventional invasive biopsies, Inivata detects and analyses genomic material from a cancer patient’s cell-free, circulating tumour DNA (ctDNA) which can be collected through a simple blood sample. This non-invasive approach – a liquid biopsy – offers a revolution in how cancer is detected, monitored and treated.

AccelerComm Ltd provides Forward Error Correction (FEC) or channel coding solutions. It provides error correction decoder for markets, such as 3G and 4G Mobile handsets and base stations, satellite standards, and communication applications. The company’s products, include Polar, 3GPP Compliant Encoding/Decoding Chain; Turbo Decoder; and LDPC, 3GPP Compliant LDPC Encoding/Decoding Chain. AccelerComm Ltd was incorporated in 2016 and is based in Southampton, United Kingdom.

C-Capture Ltd utilise their extensive knowledge of CO2 (carbon dioxide) based chemistry and engineering, to develop a bottom-up approach to designing solvent systems for the removal of CO2 from gas streams. CO2 is considered to be a ‘greenhouse gas’ and its release into the atmosphere is one of the leading contributors to global warming.

Featurespace is the world-leader in Adaptive Behavioural Analytics and creator of the ARIC™ platform, a machine learning software system developed out of the University of Cambridge. The ARIC™ platform uses anomaly detection to analyse complex behavioural data in real time, spotting anomalies to block new fraud attacks as they occur. At the same time, Featurespace recognises genuine customers without blocking their activity. ARIC™ reduces the number of genuine transactions incorrectly identified as fraud by over 70%, enabling businesses to accept more revenue. Head quartered in Cambridge, UK, and Atlanta, GA, U.S. Featurespace has deployed the ARIC™ platform to organisations that have services or products deployed in over 180 countries. Customers include Betfair, Vocalink/Zapp, Worldpay, and TSYS, the largest third-party processor of Visa® and MasterCard® credit cards in the U.S.

AudioScenic Limited, founded in 2017 and based in Southampton, United Kingdom, specializes in the development of innovative 3D audio technology that integrates head-tracking with listener-adaptive loudspeaker arrays. The company aims to transform audio experiences in various sectors, including cinema, gaming, production, portable devices, and automotive applications. By utilizing small arrays of speakers and advanced head-tracking technologies, AudioScenic delivers immersive sound without the need for headphones or conventional speaker setups. This technology allows sound to be projected directly to the listener's ears, creating a superior spatial audio experience that simulates 3D sound positioning. The proprietary head-tracking feature ensures that audio beams adjust dynamically to the listener's movements, eliminating the limitations of traditional setups. AudioScenic offers scalable solutions tailored to diverse platforms, providing detailed acoustic design support to implement its audio systems effectively. The company's Virtua 3D Engine, which employs patented signal processing techniques, enables cost-effective implementations across a range of products, reinforcing its commitment to enhancing audio quality in both personal and public spaces.

Import.io Ltd is a SaaS company that specializes in Web Data Integration, enabling users to transform extensive web data into structured, machine-readable formats. Founded in 2012 and headquartered in London, with an additional office in Los Gatos, California, the company offers a suite of products including Import.io Extract for automated web extraction, Import.io Insights for data monitoring and visualization, Import.io API for system integration, and Import.io Transform for data formatting. Its solutions support various applications such as competitor price monitoring, MAP compliance, product matching, and customer sentiment analysis. Import.io serves over 850 clients by providing high-quality web data from millions of online sources, thereby enhancing business insights and competitive advantages.

WaveOptics, Ltd. specializes in the design and manufacture of augmented reality display technology, focusing on optical waveguides for wearable devices. The company offers features such as binocular displays, high field-of-view, and full RGB color in lightweight designs. Founded in 2014 and based in Abingdon-on-Thames, United Kingdom, WaveOptics has established strategic partnerships with companies like Compal, Wistron, and Plessey to enhance its product offerings. The company aims to be a pivotal supplier of optical components for the growing augmented reality market.

Genomics PLC develops algorithms and software solutions that focus on cancer, microbes, and rare diseases. Its solutions allow governments and healthcare providers to transform healthcare provisions for their citizens and members; pharmaceutical and biotechnology clients to de-risk the drug development process; clinicians and doctors to improve diagnoses and treatment options; and research laboratories and genome analysts to process results accurately. The company was incorporated in 2014 and is based in Oxford, United Kingdom.

Ultraleap is a leader in mid-air haptic technology and 3D hand tracking, specializing in creating tactile feedback through ultrasound. This innovative technology allows users to experience touch sensations in mid-air, enabling interactions with virtual objects, touchless buttons, and mid-air gestures without the need for physical contact. The company offers a range of products, including the Evaluation Kit, which features ultrasonic transducers and a software development kit for programming haptic sensations, and the TOUCH Development Kit, designed for creating tactile feedback in free space. Ultraleap’s technology finds applications in various sectors, including virtual reality, gaming, automotive, medical, and advertising. Established in 2013, the company operates from its headquarters in Bristol, United Kingdom, and maintains an additional office in Mountain View, California.

IBEX Innovations Limited specializes in the development and commercialization of advanced X-ray detector technology that enhances material analysis capabilities. The company's proprietary multi absorption plate (MAP) technology integrates with standard X-ray detectors, enabling high sensitivity material classification while maintaining key performance characteristics such as speed and spatial resolution. This innovative solution is applicable across various sectors, including medical imaging, electronics, food safety, and security. Founded in 2010 by Dr. Gary Gibson and based in Sedgefield, United Kingdom, IBEX has rapidly evolved from its initial concept to a recognized provider of engineered solutions. The company collaborates with academic and healthcare institutions, including Durham University and NHS trusts, to validate and advance its technology. IBEX Innovations has received support from venture capital firms and grants from InnovateUK and the European Commission to foster its growth and development.

Yoyo Wallet Limited is a mobile wallet provider based in London, United Kingdom, founded in 2013. The company offers a digital payment platform that facilitates customer transactions through smartphones, allowing users to pay for goods while simultaneously collecting loyalty rewards. Yoyo Wallet serves a variety of clients including retailers, universities, and corporate locations across the UK. The platform processes over 150,000 monthly in-store transactions and features a marketing component that enhances digital customer engagement. By leveraging purchasing patterns, Yoyo enables retailers to deliver personalized rewards and offers, transforming anonymous shoppers into identifiable customers. This approach helps retailers better target their audience and improve customer loyalty. Yoyo Wallet was previously known as JustYoyo Limited until its name change in April 2015.

Garrison Technology Limited develops technologies for enterprise cybersecurity needs. The company was incorporated in 2014 and is based in London, United Kingdom. It aims to serve the growing enterprise market with its anti-malware product. It wants to address the large and growing enterprise cyber security market. The company has pioneered in an anti-malware product that efficiently sidesteps the highest impact cyber threats to modern organizations, i.e. internet-borne targeted attacks. Due to Garrison’s unique technology, a previously inconceivable brand of ultra-secure internet connectivity, user experience, and enterprise scalability can be achieved.

Oxbotica is developing the next generation of autonomous vehicles - creating the software that makes them go. Using the latest in computer vision and machine learning, their systems learn from their environment and share experiences with each other, so that they're getting smarter all the time. The system uses a complement of sensors and algorithms to identify and track pedestrians, cars and other obstacles in the environment.

Genomics PLC develops algorithms and software solutions that focus on cancer, microbes, and rare diseases. Its solutions allow governments and healthcare providers to transform healthcare provisions for their citizens and members; pharmaceutical and biotechnology clients to de-risk the drug development process; clinicians and doctors to improve diagnoses and treatment options; and research laboratories and genome analysts to process results accurately. The company was incorporated in 2014 and is based in Oxford, United Kingdom.

Dukosi Ltd designs, develops, and manufactures battery management systems for automotive industry. It offers cell sensor products for hybrid, plug-in hybrid, and electric automotive vehicles; mobility vehicles; and smart grids. The company’s products enable monitoring the health of individual battery cells. Dukosi Ltd was founded in 2003 and is based in Edinburgh, United Kingdom.

Artios Pharma Limited is a biotechnology company based in Cambridge, United Kingdom, focused on developing innovative cancer treatments that target DNA damage response (DDR) pathways. Founded in 2015, the company aims to create first-in-class therapies that selectively kill cancer cells by exploiting the mechanisms involved in DNA repair. Its product pipeline features several promising candidates, including DNA polymerase theta (Polθ) and an in-licensed program targeting a novel DDR protein. Artios collaborates with Cancer Research Technology and leading researchers in the field to advance its development efforts. The company's leadership comprises experts with extensive experience in DDR drug discovery, and it has garnered investment from notable entities, including SV Life Sciences and AbbVie Ventures.

Spirea Ltd. operates as a healthcare technology company that has developed a smart polymer platform for the controlled delivery of drug combinations to maximise the clinical impact of medicines.

Carisma Therapeutics is a biotechnology company focused on developing innovative cellular immunotherapies to treat solid tumors. Founded in 2016 and based in Philadelphia, Pennsylvania, the company specializes in creating CAR macrophages, which utilize chimeric antigen receptor technology and adoptive cell transfer. This approach aims to enhance cancer treatment by enabling macrophages to infiltrate solid tumor microenvironments, thereby providing robust cellular immunotherapy options for patients. Carisma leverages advancements in macrophage biology and engineering to improve therapeutic outcomes in oncology.

Silicon Microgravity Limited, founded in 2014 and based in Cambridge, United Kingdom, specializes in developing advanced sensor devices for the oil and gas industry. The company emerged as a spin-out from Cambridge University, where its innovative sensor technology was created in collaboration with BP plc. This technology allows for the high-sensitivity recording of gravity data and the acquisition of seismic data at ultra-low frequencies, enhancing oil recovery and reservoir management. Additionally, Silicon Microgravity's microelectromechanical system sensors are capable of measuring densities deep within reservoirs from boreholes. Beyond the oil and gas sector, the technology also finds applications in the navigation, guidance, and stabilization of intelligent systems for commercial, industrial, and military purposes. The development of these sensors has received significant funding from BP and Innovate UK.

Lorem Therapeutics is focusing on development early stage therapeutics in the phase between initial drug discovery and when a treatment begins review by the FDA for status as an Investigational New Drug. The company will use the funding “to accelerate and enhance our drug discovery efforts around critical cancer indications,” Slusher said in a statement.

Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms. The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments that retain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.

Enterprise Therapeutics is a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases. In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlying mechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life.

OxSyBio Ltd. develops 3D printing techniques to produce tissue-like and functional tissues for medical research and clinical applications. It develops printing tissue-like materials comprised of 3-dimensional networks of lipid monolayer aqueous droplets that are used for conducting electrical signals along pre-defined pathways, and self-folding to form complex geometries. The tissues can be used in the clinic for organ repair or replacement. The company was founded in 2014 and is based in London, United Kingdom.

Econic Technologies Ltd. is a chemical technology company based in Macclesfield, United Kingdom, that specializes in developing catalysts and processes to produce polymers and polyurethanes from carbon dioxide and epoxides. Founded in 2011, the company aims to transform waste CO2 into valuable products, thereby reducing reliance on fossil fuels and contributing to environmental sustainability. Its product portfolio includes polycarbonates and polycarbonate polyols, which are utilized in various applications such as mattresses, home insulation, footwear, packaging materials, and coatings for construction surfaces. The company's innovative technologies have been patented and validated through pilot operations, with ongoing investments supporting its growth. A dedicated team of scientists and engineers operates from a modern facility at Alderley Park, focusing on advancing its mission to convert greenhouse gas emissions into beneficial commercial products.

A company at the top of its game in harnessing intelligent systems and emerging technologies. Working methodically but unobtrusively they set the gold standard in workplace automation. You can trust our proprietary and proven methodology to encapsulate your human know-how and the complex processes that characterise human decision-making.

Arkivum delivers software, services and domain expertise for long term data management and digital preservation globally. We serve organisations around the world in data intensive and regulated markets. We make your long term data secure, accessible and usable for as long as you need it, providing assurance your data is where you need it, when you need it. Our domain expertise means we can guarantee 100% data integrity and best practice guidance for dealing with new compliance requirements as they are introduced. Our vendor neutral technology and no data lock-in means your data lives where you want it to and you own your data at all times. Arkivum delivers complete confidence in preserving, meeting complex compliance and regulatory requirements and creating business value from your data. Bringing your archived data to life.

Oxehealth Ltd. is a technology company based in Oxford, United Kingdom, specializing in non-contact vital signs monitoring solutions for various sectors, including healthcare, fitness, automotive, and security. Founded in 2012, Oxehealth has developed the Oxecam software, which utilizes a digital video camera to remotely measure vital signs such as heart rate, respiratory rate, and blood oxygenation without physical contact. This innovative technology is particularly beneficial for monitoring elderly and vulnerable individuals in settings where staff presence may be limited. Oxehealth's Digital Care Assistant generates alerts regarding risky activities and provides objective data on patient activity and vital signs, enhancing care planning and allowing caregivers to focus on hands-on support. The company has achieved a world-first certification for its software as a medical device, demonstrating its commitment to transforming care environments. Oxehealth's proprietary algorithms leverage deep learning and computer vision to deliver accurate monitoring, making it a valuable tool in mental health, prison, and acute care settings.

Navenio is a software technology company that provides location-based services for indoor environments via mobile applications. Its solution provides an improvement on other indoor localization technologies, having the ability to locate people without the need for implementing, managing, or surveying any new building hardware such as beacons or wi-fi. Navenio’s intelligent workforce solution unlocks significant improvements in the efficiency and workflow of staff and teams through automation that is carefully driven from real-world best practice. The company was founded in 2015 and is headquartered in Oxford, England.

Quantum Motion Technologies Limited is focused on developing a technology platform that utilizes an array of qubits to create innovative quantum computing architectures. Established in 2017 and based in Leeds, United Kingdom, the company aims to build a universal quantum computer using silicon and CMOS-compatible processes. Its quantum computing technology is designed to address complex challenges across various fields, including chemistry, medicine, and artificial intelligence.

Touchstone Innovations create, build and invest in pioneering technology companies and licensing opportunities developed from outstanding scientific research focusing on the ‘Golden Triangle’ of London, Cambridge and Oxford. Their robust strategy and fully integrated business model, proven over many years, begins with original idea and extends through intellectual property (IP) protection, company formation, seed funding, incubation, scale-up and supportive investment. This provides us with a unique insight into leveraging early-stage research and turning it into substantial, high-quality, well-managed and well-funded commercial businesses. They help scientists and entrepreneurs to commercialise their idea by protecting and licensing intellectual property, leading the formation of new companies, recruiting high-calibre management teams and providing and supporting investment. They provide continuity of funding from start-up to scale-up, with initial investments from seed stage onwards. They remain an active investor throughout the lifetime of their portfolio companies, with the majority of their investment each year going into businesses they have lived with and understood for some time. This strategy substantially de-risks investment scale-up in their portfolio companies. Touchstone Innovations is at the forefront of UK early-stage technology investment. Alongside their co-investors they have leveraged over £1.5 billion to help drive high technology innovation in the UK.

Ionix Advanced Technologies Ltd. specializes in the development and supply of high-performance piezoelectric devices and materials designed for high-temperature applications. Founded in 2011 and based in Leeds, United Kingdom, the company offers a diverse range of products, including sensors, actuators, and transducer devices that utilize its advanced piezoelectric materials. These devices are engineered to operate effectively in extreme environments, making them suitable for various industries such as aerospace, oil and gas, nuclear power, automotive, and non-destructive testing (NDT). Ionix's technology aims to reduce energy and operating costs while enhancing reliability and safety, particularly in applications requiring continuous operation under challenging conditions, including high temperatures and ionizing radiation.

Inductosense is developing wireless, battery-free, sensors that can be permanently fixed to a product or structure for fast, repeatable inspections of cracks, defects or corrosion. The sensors can operate underneath coatings, insulation or repairs and can also be embedded into a material. They are entirely passive and the power and signal are provided remotely by non-contact inductive coupling from a handheld measurement probe . The technology is referred to as the Wireless And Non Destructive (WAND) system.

Zeetta Networks Limited specializes in developing and marketing open networking solutions that leverage software-defined networking (SDN) and network virtualization technologies. Established in 2015 as a spin-out from the High-Performance Networks Group of Bristol University, the company offers NetOS, a network operating system designed for heterogeneous networks. NetOS facilitates the plug-and-play management of diverse network devices and supports the creation of virtual network slices for various applications, including ultra-HD video distribution and Internet of Things deployments. The platform also incorporates a Virtualization Engine, allowing for the efficient sharing of network resources while ensuring guaranteed Quality of Service for users. In addition to its core software solutions, Zeetta Networks provides integration, support, and training services, catering to network operators, enterprises, original equipment manufacturers, and data centers. The company has engaged with major industry players, highlighting its strong market presence and innovative capabilities.

Eight19 Limited manufactures organic photovoltaics (OPVs) modules for light-weight solar panels. It offers OPV modules for indoor energy harvesting, outdoor, and off-grid applications. The company also provides integrated demonstration units, such as indoor Bluetooth-connected temperature and light sensors powered. Its products are used in wireless devices, retail, and outdoor off-grid applications. Eight19 Limited was founded in 2010 and is based in Cambridge, United Kingdom.

Zilico Limited is a Manchester-based company focused on developing diagnostic devices aimed at improving cancer detection, particularly cervical cancer. Utilizing electrical impedance spectroscopy technology, Zilico's flagship product, ZedScan, operates alongside colposcopy to provide real-time, objective assessments of cervical epithelial tissue. This technology addresses the limitations of traditional diagnostic methods, which often involve subjective interpretations. Zilico is actively working on two applications: one targeting the referral market and another aimed at the screening market, both designed to enhance diagnostic accuracy and reduce the subjectivity associated with current practices. Since its founding in 2006, Zilico has aimed to deliver significant health economic benefits and improve cancer screening programs. The company was previously known as Aperio Diagnostics Limited before rebranding in 2008.

Carisma Therapeutics is a biotechnology company focused on developing innovative cellular immunotherapies to treat solid tumors. Founded in 2016 and based in Philadelphia, Pennsylvania, the company specializes in creating CAR macrophages, which utilize chimeric antigen receptor technology and adoptive cell transfer. This approach aims to enhance cancer treatment by enabling macrophages to infiltrate solid tumor microenvironments, thereby providing robust cellular immunotherapy options for patients. Carisma leverages advancements in macrophage biology and engineering to improve therapeutic outcomes in oncology.

Creavo Medical Technologies Ltd. is a UK-based medical device company focused on developing innovative imaging technologies for acute medical settings. Established in 2014, the company was founded by a team of clinical, research, and business experts to commercialize technology created by Professor Ben Varcoe. Creavo offers a portable, battery-powered medical device designed for the detection of heart-related issues, enhancing diagnostic capabilities in urgent care environments. The company operates facilities in Leeds and Coventry, aiming to improve patient outcomes through advanced diagnostic solutions.

Alesi Surgical Ltd. specializes in developing and commercializing laparoscopic surgical smoke handling systems aimed at enhancing the safety and outcomes of surgical procedures. Founded in 2009 as a spin-out from the Welsh Institute for Minimal Access Therapy, the company has a strong connection to experienced surgeons and trainers, enabling it to identify and address challenges in surgical techniques. Alesi Surgical distributes its products to hospitals across Europe, the Middle East, New Zealand, and Australia. Established in Cardiff, United Kingdom, the company was previously known as Asalus Medical Instruments Limited and has been operational since 2007.

Ultraleap is a leader in mid-air haptic technology and 3D hand tracking, specializing in creating tactile feedback through ultrasound. This innovative technology allows users to experience touch sensations in mid-air, enabling interactions with virtual objects, touchless buttons, and mid-air gestures without the need for physical contact. The company offers a range of products, including the Evaluation Kit, which features ultrasonic transducers and a software development kit for programming haptic sensations, and the TOUCH Development Kit, designed for creating tactile feedback in free space. Ultraleap’s technology finds applications in various sectors, including virtual reality, gaming, automotive, medical, and advertising. Established in 2013, the company operates from its headquarters in Bristol, United Kingdom, and maintains an additional office in Mountain View, California.

SAW DX Ltd, a technology development company, designs and manufactures point of care (POC) diagnostic devices. Its portfolio includes development of POC board and wires prototype for use in diagnosis of sexually transmitted infections; POC demonstrator reader and disposable cartridge for use with existing diagnostic assays for tuberculosis (including latent TB); and a platform to enrich parasites and perform cell lysis and molecular detection on low-cost disposable chips. The company serves life sciences and diagnostics companies. SAW DX Ltd was incorporated in 2013 and is headquartered in Glasgow, United Kingdom.

Dukosi Ltd designs, develops, and manufactures battery management systems for automotive industry. It offers cell sensor products for hybrid, plug-in hybrid, and electric automotive vehicles; mobility vehicles; and smart grids. The company’s products enable monitoring the health of individual battery cells. Dukosi Ltd was founded in 2003 and is based in Edinburgh, United Kingdom.

Refract Software Ltd develops sales coaching software. It provides conversation intelligence and video coaching platform. The company was founded in 2015 and is based in Stockport, United Kingdom.

Parkwalk Advisors Ltd is a London-based venture capital firm that specializes in investing in growth capital and spin-outs from UK universities and research-intensive institutions. Founded in 2009, the firm targets a wide range of sectors, including healthcare, technology, energy, and life sciences, focusing particularly on companies with intellectual property backing. Parkwalk invests in various stages of company development, from seed to growth capital, typically committing between £250,000 and £10 million. The firm seeks to capitalize on the UK government's tax incentives for innovative technology companies, aiming to generate significant capital gains for investors. With an emphasis on companies based in the UK, particularly in Cambridge, Parkwalk leverages extensive academic and venture capital networks to access high-quality deal flow. As of 2017, it operates as a subsidiary of IP Group Plc, enhancing its capabilities in intellectual property commercialization.

Microbiotica Limited is a biotechnology company based in Cambridge, United Kingdom, founded in 2016. The company specializes in the development of human microbiome-based therapeutics and biomarkers. Its platform is designed to identify gut bacteria associated with specific phenotypes, offering a high level of precision. This capability allows researchers to determine phenotypes before conducting tests on candidate bacteria using advanced in vitro and in vivo models. By focusing on the science of the microbiome, Microbiotica aims to advance the understanding and application of live bacterial therapeutics in clinical settings.

Oxford Nanopore Technologies Limited specializes in the development and commercialization of nanopore-based electronic systems for the analysis of single molecules, particularly in the fields of DNA and RNA sequencing. The company offers a range of products, including the portable MinION device for molecular analysis, the benchtop PromethION for large-scale sequencing projects, and the GridION system suitable for various molecular sensing applications. Their technology supports diverse scientific research areas such as genomics, cancer studies, microbiology, and environmental research, with applications extending to healthcare, agriculture, and food safety. The Flongle device caters to on-demand sequencing needs, while the MinIT accessory enhances the functionality of their sequencing devices. Oxford Nanopore’s innovative technology emphasizes accessibility and ease of use, with rapid library preparation and automated processes. Founded in 2005 and headquartered in Oxford, United Kingdom, the company operates additional offices worldwide, enabling its products to be utilized in over 80 countries.

AccelerComm Ltd provides Forward Error Correction (FEC) or channel coding solutions. It provides error correction decoder for markets, such as 3G and 4G Mobile handsets and base stations, satellite standards, and communication applications. The company’s products, include Polar, 3GPP Compliant Encoding/Decoding Chain; Turbo Decoder; and LDPC, 3GPP Compliant LDPC Encoding/Decoding Chain. AccelerComm Ltd was incorporated in 2016 and is based in Southampton, United Kingdom.

Exyn Technologies, Inc. is a Philadelphia-based company specializing in autonomous aerial robotics, having emerged from the GRASP Laboratory at the University of Pennsylvania. Founded in 2014, the company has developed exynAI, a modular software system that enables pilot-less flights for drones in complex commercial settings. This technology leverages multiple redundant sensors and advanced mapping techniques to facilitate obstacle avoidance and autonomous flight planning, allowing for applications such as underground inspections, inventory management, and construction documentation. Exyn's drones operate without human control or GPS, making them particularly suited for navigating challenging environments and automating hazardous tasks.